Two Corning Radiation-Shielding Glass Products Now Registered with FDA

We use cookies to ensure the best experience on our website.
View Cookie Policy
_self
Accept Cookie Policy
Change My Settings
ESSENTIAL COOKIES
Required for the site to function.
PREFERENCE AND ANALYTICS COOKIES
Augment your site experience.
SOCIAL AND MARKETING COOKIES
Lets Corning work with partners to enable social features and marketing messages.
ALWAYS ON
ON
OFF

Two Corning Radiation-Shielding Glass Products Now Registered with FDA

Two Corning Radiation-Shielding Glass Products Now Registered with FDA

News Releases
Corporate Communications
Two Corning Radiation-Shielding Glass Products Now Registered with FDA
Two Corning Radiation-Shielding Glass Products Now Registered with FDA
CORNING, N.Y. | Corning Incorporated | June 04, 2019
Glass solutions used as Class I medical devices

Corning Incorporated (NYSE: GLW) announced today that two of its products – Corning® Med-X® Glass and Corning® Med-Gamma® Glass – are now registered as compliant with U.S. Food and Drug Administration (FDA) regulations. This compliance demonstrates Corning’s commitment to supporting public health, safety, and security through high-quality radiation-shielding glass.

“With this registration, Corning becomes the first radiation-shielding glass manufacturer on the market to provide its customers and their end-customers with full compliance and traceability adhering to FDA requirements,” said Pierre-Jean Baron, general manager, Corning Specialty Glass.
 
Corning is a world leader in radiation shielding glass solutions for medical, nuclear, and industrial applications. In partnership with strategic distributors, equipment manufacturers, and shielding specialists around the world, Corning developed a comprehensive radiation shielding range with global production capabilities to complement its innovative glass solutions portfolio.

As per U.S. regulations, Corning registered with the FDA for Corning® Med-X® Glass and Corning® Med-Gamma® Glass under the classification of Radiology devices / Personnel protective shield. These two glass product categories are used as Class I medical devices as defined by the FDA.

The FDA is responsible for advancing the public health by helping to speed innovations that make medical products more effective and safer. It is also responsible for helping the public get the accurate, science-based information they need to use medical products and foods. Corning is engaging with the FDA on multiple fronts including streamlining adoption of Corning Valor® Glass, the company’s new, revolutionary pharmaceutical glass packaging.

Information on U.S. regulatory requirements for Class 1 medical devices can be found in the FDA Device section at this link:https://www.fda.gov/medical-devices/importing-and-exporting-devices/importing-us

Caution Concerning Forward-Looking Statements
The statements contained in this release that are not historical facts or information and contain words such as “will,” “believe,” “anticipate,” “expect,” “intend,” “plan,” “seek,” “see,” “would,” and “target” and similar expressions are forward-looking statements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include estimates and assumptions related to economic, competitive and legislative developments. Such statements relate to future events that by their nature address matters that are, to different degrees, uncertain. These estimates are subject to change and uncertainty which are, in many instances, beyond our control. There can be no assurance that future developments will be in accordance with management’s expectations. Actual results could differ materially from those expected by us, depending on the outcome of various factors. We do not undertake to update forward-looking statements. 

Some of the risks, uncertainties and other factors that could cause actual results to differ materially from those expressed in or implied by the forward-looking statements include, but are not limited to: the effects of acquisitions, dispositions and other similar transactions, global business, financial, economic and political conditions; tariffs and import duties; currency fluctuations between the U.S. dollar and other currencies, primarily the Japanese yen, euro, Chinese yuan and South Korean won; product demand and industry capacity; competitive products and pricing; availability and costs of critical components and materials; new product development and commercialization; order activity and demand from major customers; the amount and timing of our cash flows and earnings and other conditions, which may affect our ability to pay our quarterly dividend at the planned level or to repurchase shares at planned levels; possible disruption in commercial activities due to terrorist activity, cyber-attack, armed conflict, political or financial instability, natural disasters, or major health concerns; unanticipated disruption to equipment, facilities, IT systems or operations; effect of regulatory and legal developments; ability to pace capital spending to anticipated levels of customer demand; rate of technology change; ability to enforce patents and protect intellectual property and trade secrets; adverse litigation; product and components performance issues; retention of key personnel; customer ability, most notably in the Display Technologies segment, to maintain profitable operations and obtain financing to fund their ongoing operations and manufacturing expansions and pay their receivables when due; loss of significant customers; changes in tax laws and regulations including the Tax Cuts and Jobs Act of 2017; the impacts of audits by taxing authorities; and the potential impact of legislation, government regulations, and other government action and investigations.

For a complete listing of risks and other factors, please reference the risk factors and forward-looking statements described in our annual reports on Form 10-K and quarterly reports on Form 10-Q.

Web Disclosure
In accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated (“Corning”) wishes to notify investors, media, and other interested parties that it uses its website (http://www.corning.com/worldwide/en/about-us/news-events.html) to publish important information about the company, including information that may be deemed material to investors, or supplemental to information contained in this or other press releases. The list of websites and social media channels that the company uses may be updated on Corning’s media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company’s SEC filings, press releases, conference calls, and webcasts.

About Corning Incorporated
Corning (www.corning.com) is one of the world's leading innovators in materials science, with a more than 165-year track record of life-changing inventions. Corning applies its unparalleled expertise in glass science, ceramic science, and optical physics along with its deep manufacturing and engineering capabilities to develop category-defining products that transform industries and enhance people's lives. Corning succeeds through sustained investment in RD&E, a unique combination of material and process innovation, and deep, trust-based relationships with customers who are global leaders in their industries.

Corning's capabilities are versatile and synergistic, which allows the company to evolve to meet changing market needs, while also helping our customers capture new opportunities in dynamic industries. Today, Corning's markets include optical communications, mobile consumer electronics, display technology, automotive, and life sciences vessels. Corning's industry-leading products include damage-resistant cover glass for mobile devices; precision glass for advanced displays; optical fiber, wireless technologies, and connectivity solutions for state-of-the-art communications networks; trusted products to accelerate drug discovery and delivery; and clean-air technologies for cars and trucks.